Vertaling van "fractures in postmenopausal " (Nederlands → Frans) :

hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women.
49. NICE. Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women.

Effect of paratyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med, 344, pp.1434-41.
Effect of paratyroid hormone (1-34) on fractures and bone mineral density in

It is approved for up to six indications involving the treatment of osteoporosis in men and postmenopausal women, including those who have experienced a low-trauma hip fracture.
Il est maintenant autorisé pour jusqu’à six indications impliquant le traitement de l’ostéoporose chez l’homme et la femme postménopausée, y compris chez ceux qui ont souffert d’une fracture peu traumatique de la hanche.